3 ms·
There’s a specific regulatory pathway for this process, section 505(b)(2). It allows you to use the safety data for the approved treatments which can save you
by gumby 6y ago
There’s a specific regulatory pathway for this process, section 505(b)(2). It allows you to use the safety data for the approved treatments which can save you a lot of time and money (I have used this route for a drug myself T one of my companies).
You still have to prove that your formulation is safe,of course, and prove efficacy for the situation you intend to market it for.
- dstick 6y agoGotcha, and that makes sense. Seems like a big time saver regardless. Are we talking months or years, that are shaved off?
- gumby 6y agoTypically years. We had a program for a drug that caused bladder cancer in rats. The original mfr had spent a couple of years figuring out that it was specific to rats. I think the current stats are that the average drug time to approval is 14 years.